Calico Life Sciences at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Calico Life Sciences at ASHG 2026 in Montréal: 1 presentation (1 platform talk).

OrganizationASHG 2026 Attendance
Calico Life Sciences
San Francisco, California
1 Machine Learning Scientist
Subsidiary
Calico develops first-in-class therapies for age-related diseases and translates aging biology into potential medicines for patients.
Its drug fosigotifator won FDA Breakthrough Therapy Designation for treating vanishing white matter disease, speeding its regulatory path.
›
Its drug fosigotifator won FDA Breakthrough Therapy Designation for treating vanishing white matter disease, speeding its regulatory path.
2026-06 · source
Partnered with Nexo to discover and develop small-molecule therapies aimed at age-related diseases.
2026-05 · source
Appointed Joseph Arron as head of human biology and genetics, a leadership hire in its research organization.
2026-02 · source
Source: company newsroom
Currently hiring: 15 open roles
›
Source: careers page
Talk
Thu Oct 22
9:30 am

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Calico Life Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction